{
    "clinical_study": {
        "@rank": "99096", 
        "arm_group": [
            {
                "arm_group_label": "Roxolid dental implant, 4.1 mm diameter", 
                "arm_group_type": "Active Comparator", 
                "description": "Straumann Bone Level \u00d84.1 mm RC SLActive Roxolid Implant available in lengths 8mm, 10mm, 12mm and 14mm"
            }, 
            {
                "arm_group_label": "Roxolid dental implant, 3.3 mm diameter", 
                "arm_group_type": "Experimental", 
                "description": "Straumann Bone Level \u00d83.3 mm NC SLActive Roxolid Implant available in 8mm, 10mm, 12mm, and 14mm"
            }
        ], 
        "brief_summary": {
            "textblock": "The primary objective of this study is to demonstrate non-inferiority of the Straumann Bone\n      Level \u00d8 3.3 mm NC SLActive Roxolid Implants compared to Straumann Bone Level \u00d8 4.1 mm RC\n      SLActive Roxolid Implants based on mean crestal bone level changes measured between surgery\n      and 12 months post-implant placement.  The secondary objectives will assess differences in\n      clinical outcomes between the test and control implants, including implant success and\n      survival, gingival recession, subject satisfaction and additional early bone level\n      measurements."
        }, 
        "brief_title": "Straumann Roxolid Multi-Center Study", 
        "completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Jaw, Edentulous, Partially", 
        "condition_browse": {
            "mesh_term": [
                "Jaw, Edentulous", 
                "Jaw, Edentulous, Partially", 
                "Mouth, Edentulous"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects must have voluntarily signed the informed consent form\n\n          -  Subjects must be males or females who are a minimum of 20 years of age\n\n          -  Subjects must have a single tooth gap in the pre-molar or anterior region of the\n             mandible or maxilla (ADA tooth positions 4-13 and 20-29; FDI tooth positions 11-15,\n             21-25, 31-35, and 41-45)\n\n          -  Subjects must have opposing dentition (natural teeth, fixed or removable\n             restorations)\n\n          -  Subjects must have a full mouth plaque score \u2264 25%, according to O'Leary, at the time\n             of screening\n\n          -  Subjects must have adequate bone to encapsulate the implant and allow placement of an\n             \u00d8 4.1 mm Bone Level Implant.\n\n          -  Adequate bone height of at least 1 mm longer than the length of the study implant\n\n          -  Subjects must have substantially healed (at least 16 weeks after tooth extraction)\n             extraction sockets\n\n          -  Subjects must be committed to the study and the required follow-up visits\n\n          -  Subjects must be in good general health as assessed by the Investigator\n\n        Exclusion Criteria:\n\n          -  Subjects with a systemic disease that would preclude dental implant surgery (e.g.\n             serious internal medical problems, disorders of bone metabolism, uncontrolled\n             bleeding disorders, weakened immune system, illness requiring periodic use of\n             steroids, uncontrollable endocrine disorders, uncontrolled diabetes)\n\n          -  Subjects with any contraindications for oral surgical procedures (e.g. inadequate\n             wound healing capacity, poor oral hygiene, maxillary and mandibular growth not\n             completed, xerostomia)\n\n          -  Subjects with mucosal diseases (e.g., erosive lichen planus) in the localized area\n             around the study implant site\n\n          -  Subjects with a history of local irradiation therapy in the head/neck area\n\n          -  Subjects with any untreated endodontic lesions or untreated periodontal disease\n             adjacent to the implant site\n\n          -  Subjects receiving, or having a history of receiving, intravenous or subcutaneous\n             antiresorptive agents, such as bisphosphonates\n\n          -  Subjects with severe bruxing, parafunctional habits, or temporomandibular joint\n             dysfunction\n\n          -  Subjects with existing implants in the adjacent positions to the planned implant site\n\n          -  Subjects requiring bone augmentation or socket grafting within 6 months prior to\n             surgery\n\n          -  Subjects requiring more than minimal simultaneous augmentation for minimal buccal\n             dehiscence defects (defect cannot be greater than 3mm in height)\n\n          -  Subjects with inadequate oral hygiene or who are unmotivated for adequate home care\n\n          -  Subjects who have physical or mental handicaps that would interfere with the ability\n             to perform adequate oral hygiene\n\n          -  Subjects who are pregnant or intending to become pregnant during the duration of the\n             study\n\n          -  Subjects who are heavy smokers (defined as >10 cigarettes per day or >1 cigar per\n             day) or chew tobacco\n\n          -  Subjects who abuse alcohol or drugs\n\n          -  Subjects who have undergone administration of any investigational device within 30\n             days of enrollment in the study\n\n          -  Subjects with conditions or circumstances, in the opinion of the Investigator, which\n             would prevent completion of study participation or interfere with analysis of study\n             results, such as history of non-compliance or unreliability"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01842958", 
            "org_study_id": "CR 10/09"
        }, 
        "intervention": [
            {
                "arm_group_label": "Roxolid dental implant, 4.1 mm diameter", 
                "description": "Placement of the Straumann Bone Level \u00d84.1 mm RC SLActive Roxolid Implant available in lengths 8mm, 10mm, 12mm, and 14mm for single tooth replacement in the anterior and pre-molar region.", 
                "intervention_name": "Roxolid dental implant, 4.1 mm diameter", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Roxolid dental implant, 3.3 mm diameter", 
                "description": "Placement of Straumann Bone Level \u00d83.3 mm NC SLActive Roxolid Implant available in 8mm, 10mm, 12mm, and 14mm for single tooth replacement in the anterior and pre-molar region.", 
                "intervention_name": "Roxolid dental implant, 3.3 mm diameter", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "Dental Implant", 
        "lastchanged_date": "April 11, 2014", 
        "location": [
            {
                "contact": {
                    "email": "taghaloo@dentistry.ucla.edu", 
                    "last_name": "Tara L. Aghaloo, DDS, MD, PhD", 
                    "phone": "310-794-7070"
                }, 
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90095-1668"
                    }, 
                    "name": "UCLA School of Dentistry"
                }, 
                "investigator": {
                    "last_name": "Tara L. Aghaloo, DDS, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "sdibart@bu.edu", 
                    "last_name": "Serge Dibart, DDS, DMD", 
                    "phone": "617-638-4762"
                }, 
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02118"
                    }, 
                    "name": "Boston University, School of Dental Medicine"
                }, 
                "investigator": {
                    "last_name": "Serge Dibart, DDS, DMD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10019-5404"
                    }, 
                    "name": "New York University College of Dentistry"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "email": "huynhba@uthsca.edu", 
                    "last_name": "Guy Huynh-Ba, DDS", 
                    "phone": "210-567-3604"
                }, 
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78229"
                    }, 
                    "name": "Univeristy of Texas Health Science Center San Antonio"
                }, 
                "investigator": {
                    "last_name": "Guy Huynh-Ba, DDS", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "rboneal@uw.edu", 
                    "last_name": "Robert B. O'Neal, DMD", 
                    "phone": "206-915-9178"
                }, 
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98195-7444"
                    }, 
                    "name": "University of Washington"
                }, 
                "investigator": {
                    "last_name": "Robert B. O'Neal, DMD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized, Controlled, Multi-center Clinical Study Evaluating the Crestal Bone Level Change of Straumann Bone Level \u00d8 3.3 mm NC SLActive Roxolid Implants Compared to Straumann Bone Level \u00d8 4.1 mm RC SLActive Roxolid Implants for Single Tooth Replacement in the Anterior and Pre-molar Region", 
        "overall_contact": {
            "email": "kelly.jork@straumann.com", 
            "last_name": "Kelly Jork, MS", 
            "phone": "978-747-2533"
        }, 
        "overall_official": {
            "affiliation": "University of Texas Health Science Center San Antonio", 
            "last_name": "David L. Cochran, DDS, MS, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Mean crestal bone level change between implant placement and 12 months post loading as determined by radiographic measurement of mesial and distal bone levels following placement of a Straumann Bone Level \u00d83.3 mm NC SLActive Roxolid Implant versus a Straumann Bone Level \u00d84.1 mm RC SLActive Implant in the anterior or pre-molar region of the mandible or maxilla.", 
            "measure": "Mean crestal bone level change", 
            "safety_issue": "No", 
            "time_frame": "12 months post loading"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01842958"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Additional radiographic evaluation of mesial and distal crestal bone level changes between implant placement and at 25 days post post implant placement, 6 months post loading, and 12 months post loading", 
                "measure": "Additional mean crestal bone level changes", 
                "safety_issue": "No", 
                "time_frame": "25 days, 6 months post loading, and 12 months post loading"
            }, 
            {
                "measure": "Implant success rate", 
                "safety_issue": "No", 
                "time_frame": "25 days, 6 months post loading, and 12 months post loading"
            }, 
            {
                "measure": "Implant survival rate", 
                "safety_issue": "No", 
                "time_frame": "7 days, 25 days, 6 months post loading, and 12 months post loading"
            }, 
            {
                "measure": "Gingival recession", 
                "safety_issue": "No", 
                "time_frame": "6 months post loading and 12 months post loading"
            }, 
            {
                "measure": "Incidence of adverse events and adverse device effects", 
                "safety_issue": "Yes", 
                "time_frame": "Surgical visit, 7 days, 25 days, 6 months post loading, and 12 months post loading"
            }, 
            {
                "description": "Subject satisfaction will be assessed utilizing Visual Analogs Scales (VAS)", 
                "measure": "Subject satisfaction", 
                "safety_issue": "No", 
                "time_frame": "12 months post loading"
            }
        ], 
        "source": "Institut Straumann AG", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Institut Straumann AG", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}